LEVIPILL 500

About

Levetiracetam, the active ingredient in LEVIPILL 500, is an antiepileptic drug (AED) primarily used to manage various types of seizures. It exerts its therapeutic effect by selectively binding to synaptic vesicle protein 2A (SV2A) in the brain, a mechanism believed to modulate neurotransmitter release and prevent the hypersynchronization of neuronal activity that characterizes epileptic seizures. This action helps to stabilize neuronal membranes and reduce seizure frequency and severity.

It is commonly prescribed as adjunctive therapy for partial-onset seizures, with or without secondary generalization, in adults and children. Furthermore, it is indicated for the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy and primary generalized tonic-clonic seizures. Levetiracetam is valued for its broad spectrum of activity, relatively favorable pharmacokinetic profile, and fewer significant drug-drug interactions compared to many other AEDs, making it a versatile option in epilepsy management.

Uses

• Treatment of partial-onset seizures (with or without secondary generalization).
• Management of myoclonic seizures in juvenile myoclonic epilepsy.
• Therapy for primary generalized tonic-clonic seizures.
• Adjunctive treatment for various seizure types in adults and children.

Directions For Use

Take LEVIPILL 500 orally, usually twice daily, with or without food, as directed by your physician. Do not discontinue treatment abruptly without medical advice.

Benefits

• Effective in controlling a wide range of seizure types.
• Generally well-tolerated with a favorable safety profile.
• Minimal significant drug-drug interactions compared to other AEDs.
• Can be used as both monotherapy and adjunctive therapy.
• Available in multiple formulations for flexible administration.
• Relatively rapid onset of action for seizure control.

Side Effects

• Drowsiness or somnolence
• Dizziness
• Asthenia (weakness)
• Headache
• Nausea
• Diarrhea
• Irritability
• Aggression or behavioral changes
• Anorexia (loss of appetite)
• Infection (e.g., nasopharyngitis)
• Coordination difficulties
• Mood swings

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can increase central nervous system (CNS) depression and exacerbate side effects like dizziness and drowsiness.
• Pregnancy - Use during pregnancy only if the potential benefit outweighs the potential risk to the fetus. Consult a doctor; pregnancy registry enrollment is recommended.
• Breastfeeding - Levetiracetam is excreted in breast milk. Breastfeeding is generally not recommended or should be done with caution and medical supervision.
• Liver - Generally, no dose adjustment is needed for mild to moderate hepatic impairment. Use with caution in severe cases; monitor liver function.
• Kidney - Dose adjustment is required for patients with impaired renal function due to renal excretion. Consult a physician for appropriate dosing.
• Lung - No specific dose adjustments or contraindications related to primary lung conditions are typically required. Use with caution if respiratory depression is a concern from other CNS depressants.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.